Ophthalmic use: Infants less than 3 months of age, primary glaucoma or a tendency toward glaucoma, adhesions between the iris and the lens, geriatric clients and others where undiagnosed glaucoma or excessive pressure in the eye may be present, in children who have had a previous severe systemic reaction to atropine. Special Concerns: Use with caution in infants, small children, geriatric clients, diabetes, hypo- or hyper-thyroidism, narrow anterior chamber angle, individuals with Down syndrome.
Additional Side Effects: Ophthalmologic: Blurred vision, stinging, increased intraocular pressure, contact dermatitis. Long-term use may cause irritation, photophobia, eczematoid dermatitis, conjunctivitis, hyperemia, or edema.
How Supplied: Injection: 0.05 mg/mL, 0.1 mg/mL, 0.4 mg/mL, 0.5 mg/mL, 0.8 mg/mL, 1 mg/mL; Ophthalmic Ointment: 1%; Ophthalmic Solution: 0.5%, 1%; Tablet: 0.4 mg
Was this article helpful?